Get your founder story featured
Women Can Startup
Easiofy Solutions logo

Medical / Pharma · Greater Noida, Uttar Pradesh

Easiofy Solutions

AI medical-imaging platform (ImagiXAI) for tier-2/3 hospitals and diagnostic centres.

Founded by Meenal Gupta, Noor Fatma, Sheetal Tarkas

Snapshot

Founded
2022
Headquarters
Greater Noida, Uttar Pradesh
Business model
HealthTech
Funding stage
Pre-Seed
Markets
India
Last updated
26 June 2026

About Easiofy Solutions

Founded in 2022, Easiofy Solutions is a women-led medical and life-sciences company headquartered in Greater Noida, Uttar Pradesh. Its founders are Meenal Gupta, Noor Fatma and Sheetal Tarkas. It primarily serves hospitals and clinics and healthcare providers. The company has reached the Pre-Seed stage.

Founders

Meenal Gupta

Woman Founder

Founder & CEO

Noor Fatma

Woman Founder

Co-founder & CTO

Sheetal Tarkas

Woman Founder

Co-founder & COO

Industry classification

Medical / Pharma AI Diagnostics

Funding

Total raised~₹1.8 CrLatest roundPre-Seed

Investors: IIT Mandi Catalyst, IIM Lucknow EIC

Ideal customers

Hospitals & clinicsHealthcare providers

Typical customer segments for a medical / pharma company.

Website, social

Related women-led startups

More in Medical / Pharma.

Other Pre-Seed women-led companies

All Pre-Seed companies →

Frequently asked questions

What does Easiofy Solutions do?
Founded in 2022, Easiofy Solutions is a women-led medical and life-sciences company headquartered in Greater Noida, Uttar Pradesh. Its founders are Meenal Gupta, Noor Fatma and Sheetal Tarkas. It primarily serves hospitals and clinics and healthcare providers. The company has reached the Pre-Seed stage.
Who founded Easiofy Solutions?
Easiofy Solutions was founded by Meenal Gupta, Noor Fatma and Sheetal Tarkas.
Where is Easiofy Solutions headquartered?
Easiofy Solutions is headquartered in Greater Noida, Uttar Pradesh, India.
Is Easiofy Solutions funded?
Easiofy Solutions is at the pre-seed stage.
When was Easiofy Solutions founded?
Easiofy Solutions was founded in 2022.